![Effects of the Addition of Bevacizumab or Iniparib to Standard Chemotherapy for Breast Cancer, Including Triple-Negative Disease, in the Neoadjuvant and Metastatic Settings | Research To Practice Effects of the Addition of Bevacizumab or Iniparib to Standard Chemotherapy for Breast Cancer, Including Triple-Negative Disease, in the Neoadjuvant and Metastatic Settings | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/5MJCASCO2011/Breast/2/Slide3_0.jpg)
Effects of the Addition of Bevacizumab or Iniparib to Standard Chemotherapy for Breast Cancer, Including Triple-Negative Disease, in the Neoadjuvant and Metastatic Settings | Research To Practice
![Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions | Journal of Medicinal Chemistry Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c01180/asset/images/medium/jm0c01180_0023.gif)
Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions | Journal of Medicinal Chemistry
![Triple negative breast cancer (Ki67 = 60%, HER2 negative) presenting as... | Download Scientific Diagram Triple negative breast cancer (Ki67 = 60%, HER2 negative) presenting as... | Download Scientific Diagram](https://www.researchgate.net/publication/309817268/figure/fig2/AS:427267466764290@1478879910170/Triple-negative-breast-cancer-Ki67-60-HER2-negative-presenting-as-mass-with.png)
Triple negative breast cancer (Ki67 = 60%, HER2 negative) presenting as... | Download Scientific Diagram
![Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187 | Oncogenesis Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187 | Oncogenesis](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41389-020-0220-5/MediaObjects/41389_2020_220_Fig1_HTML.png)
Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187 | Oncogenesis
![Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer - ScienceDirect Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365921006520-ga1.jpg)
Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer - ScienceDirect
![RNF181 modulates Hippo signaling and triple negative breast cancer progression | Cancer Cell International | Full Text RNF181 modulates Hippo signaling and triple negative breast cancer progression | Cancer Cell International | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12935-020-01397-3/MediaObjects/12935_2020_1397_Fig1_HTML.png)
RNF181 modulates Hippo signaling and triple negative breast cancer progression | Cancer Cell International | Full Text
![Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells | eLife Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells | eLife](https://iiif.elifesciences.org/lax/66155%2Felife-66155-fig8-v2.tif/full/1500,/0/default.jpg)
Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells | eLife
![Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate | Anticancer Research Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/36/6/2759/F1.large.jpg)
Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate | Anticancer Research
![Cancers | Free Full-Text | Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer Cancers | Free Full-Text | Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer](https://www.mdpi.com/cancers/cancers-14-00803/article_deploy/html/images/cancers-14-00803-g001-550.jpg)
Cancers | Free Full-Text | Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer
![Deep learning-based system for automatic prediction of triple-negative breast cancer from ultrasound images | Medical & Biological Engineering & Computing Deep learning-based system for automatic prediction of triple-negative breast cancer from ultrasound images | Medical & Biological Engineering & Computing](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11517-022-02728-4/MediaObjects/11517_2022_2728_Figa_HTML.png)
Deep learning-based system for automatic prediction of triple-negative breast cancer from ultrasound images | Medical & Biological Engineering & Computing
Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: In Vitro and Molecular Docking Studies | ACS Pharmacology &
![Separations | Free Full-Text | The Role of Selective Flavonoids on Triple-Negative Breast Cancer: An Update Separations | Free Full-Text | The Role of Selective Flavonoids on Triple-Negative Breast Cancer: An Update](https://www.mdpi.com/separations/separations-10-00207/article_deploy/html/images/separations-10-00207-g001.png)
Separations | Free Full-Text | The Role of Selective Flavonoids on Triple-Negative Breast Cancer: An Update
![CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer | Cell Death & Disease CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-023-05608-3/MediaObjects/41419_2023_5608_Fig1_HTML.png)